Immunomodulation by exogenous surfactant: Effect on TNF-α secretion and luminol-enhanced chemiluminescence activity by murine macrophages stimulated with group B streptococci

Microbes and Infection

Volumn 3, Issue 4, 2001, Pages 267-273

  Talati, Ajay J ^a   Crouse, Dennis T ^c   Keith English, B ^a,b   Newman, Cynthia ^a   Harrison, Lisa ^a   Meals, Elizabeth ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Free oxygen radicals; Inflammation

Indexed keywords

LUMINOL; LUNG SURFACTANT EXTRACT; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNOMODULATION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NEWBORN SEPSIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIA;

BOVINAE; MURINAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 0035037963     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(01)01379-X     Document Type: Article

References (49)

1. Early-onset group B streptococcal sepsis: A current assessment
2. Group B streptococcal infections
3. Sepsis syndrome and septic shock in pediatrics: Current concepts of terminology, pathophysiology and management
4. Interleukin-6 production by human neonatal monocytes stimulated by type III group B streptococci
5. Production of tumor necrosis factor by human cells in vitro and in vivo, induced by group B streptococci
6. Induction of tumor necrosis factor alpha by the group and type-specific polysaccharides from type III group B streptococci
7. Assisted ventilation, physiologic implications and complications
8. Oxygen radical-dependent bacterial killing and pulmonary hypertension in piglets infected with group B streptococci
9. Induction of human granulocyte chemiluminescence by bacterial lipopolysaccharides
10. Mycoplasma stimulate the production of oxidative radicals by murine peritoneal macrophages
11. Mechanism of luminol-dependent chemiluminescence of human neutrophils
12. Hydroxyl radical scavengers produce similar decreases in the chemiluminescence responses and bactericidal activities of neutrophils
13. Surfactant replacement
14. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: Final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials
15. Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits
16. Characterization of Exosurf (Surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses
17. Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf)
18. Exogenous bovine surfactant suppresses TNF alpha release by murine macrophages stimulated by genital mycoplasmas
19. Pulmonary surfactant inhibits interleukin-2-induced proliferation and the generation of lymphokine-activated killer cells
20. Modified natural porcine surfactant inhibits superoxide anions and proinflammatory mediators released by resting and stimulated human monocytes
21. Effect of surfactant on nitroblue tetrazolium reduction of polymorphonuclear leukocytes stimulated with type Ia group B streptococci
22. Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells
23. Adult respiratory distress syndrome and artificial surfactant replacement in pediatric patient
24. Bronchoscopic surfactant administration in patients with severe adult respiratory syndrome and sepsis
25. Surfactant replacement therapy in neonates with respiratory failure due to bacterial sepsis
26. Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation
27. Surfactant treatment of full-term newborns with respiratory failure
28. Genital mycoplasmas stimulate tumor necrosis factor-α and inducible nitric oxide synthase production from murine macrophage cell line
29. Group B Streptococcus infection activates nuclear factor kappa B in human cord monocytes
30. Function and activation of NF-κB in the immune system
31. Two-peak kinetic curve of the chemiluminescence in phorbol-induced macrophage
32. Stimulation of human and rat alveolar macrophages by urban air particulates: Effects on oxidant radical generation and cytokine production
33. Chemiluminescence in activated human neutrophils: Role of buffers and scavengers
34. Lipoteichoic acid from viridans streptococci induces the production of tumor necrosis factor and nitric oxide by murine macrophages
35. A non-toxic tumor necrosis factor induced by streptococcal lipoteichoic acids
36. Roles of bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci
37. Soluble antigens from group B streptococci induce cytokine production in human blood cultures
38. Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide dependent pathway. An in vitro model of neutrophil-mediated lung injury
39. Oxidative response of human neutrophils, monocytes, and alveolar macrophages induced by unopsonized surface-adherent Staphylococcus aureus
40. Comparative susceptibility of group B streptococci and Staphylococcus aureus to killing of oxygen metabolites
41. Effects of fibronectin on the interaction of polymorphonuclear leukocytes with unopsonised and antibody-opsonised bacteria
42. The fate of exogenous surfactant in neonates with respiratory distress syndrome
43. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome; Evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure
44. Surfactant protein A protects growing cells and reduces TNFα activity from LPS-stimulated macrophages
45. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection
46. Host defense capacities of pulmonary surfactant: Evidence of 'non-surfactant' functions of the surfactant system
47. Surfactant suppresses NF-κB activation in human monocytic cells